Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Nature Neuroscience|October 24, 2018
A histone acetylome-wide association study of Alzheimer's disease identifies disease-associated H3K27ac differences in the entorhinal cortexSarah J Marzi, Szi Kay Leung, Teodora Ribarska, et al.
Journal of Clinical Immunology|July 29, 2025
Molecular Interactions Between NK Cells and Acute Leukemic Cells: KIR2DL5 Drastically Limits NK Cell ResponsesEnora Ferron, Maxime Jullien, Martin Braud, et al.
Scientific Reports|October 25, 2019
Resistin expression in human monocytes is controlled by two linked promoter SNPs mediating NFKB p50/p50 binding and C-methylationDilip Kumar, Bernett Lee, Kia Joo Puan, et al.
Elife|June 13, 2025
Artificial intelligence approaches for tumor phenotype stratification from single-cell transcriptomic dataNamrata Bhattacharya, Anja Rockstroh, Sanket Suhas Deshpande, et al.
Iscience|January 14, 2026
A gene-expression module identifies circulating immune cells with enhanced recruitment to sites of inflammationDebajyoti Sinha, Thomas Laurent, Alexis Broquet, et al.
Development (Cambridge, England)|February 20, 2016
The transcription factor SOX6 contributes to the developmental origins of obesity by promoting adipogenesisShi Chi Leow, Jeremie Poschmann, Peh Gek Too, et al.
Critical Care (London, England)|March 13, 2026
Identification of a robust metabolic signature associated with hospital-acquired pneumonia and response to interferon-gamma treatment in critically ill patientsMelanie Petrier, Debajyoti Sinha, Florian P Martin, et al.
Nature Immunology|June 26, 2020
Author Correction: Alveolar macrophages are epigenetically altered after inflammation, leading to long-term lung immunoparalysisAntoine Roquilly, Cedric Jacqueline, Marion Davieau, et al.
Nature Immunology|May 20, 2020
Alveolar macrophages are epigenetically altered after inflammation, leading to long-term lung immunoparalysisAntoine Roquilly, Cedric Jacqueline, Marion Davieau, et al.
Intensive Care Medicine|April 18, 2023
Interferon gamma-1b for the prevention of hospital-acquired pneumonia in critically ill patients: a phase 2, placebo-controlled randomized clinical trialAntoine Roquilly, Bruno Francois, Olivier Huet, et al.
Pageof 6